HECTOR PONCE: Open Payments
NPI 1083485213 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,490 in 56 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $727 · 2025 $1,490
Food & beverage: $1,490
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $361 |
| Ardelyx, Inc. | 9 | $290 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $198 |
| Medtronic, Inc. | 1 | $160 |
| GlaxoSmithKline, LLC. | 4 | $127 |
| Novo Nordisk Inc | 4 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Travere Therapeutics, Inc. | 2 | $45 |
| Aurinia Pharma U.S., Inc. | 2 | $43 |
Products named: KRYSTEXXA, IBSRELA, Kerendia, ELLIPSYS VASCULAR ACCESS SYSTEM, BENLYSTA, TAVNEOS, XPHOZAH 30 MG, Wegovy.
Industry payments across NM — which companies pay providers there.
